Management in the febrile, neutropenic patient with cancer: Therapeutic considerations
- 30 June 1985
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 106 (6) , 1035-1042
- https://doi.org/10.1016/s0022-3476(85)80265-1
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Single-drug versus combination empirical therapy for gram-negative bacillary infections in febrile cancer patients with and without granulocytopeniaAntimicrobial Agents and Chemotherapy, 1984
- Postantibiotic effect of imipenem on Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1984
- Emergence of Resistance During Therapy with the Newer -Lactam Antibiotics: Role of Inducible -Lactamases and Implications for the FutureClinical Infectious Diseases, 1983
- In vitro antagonism of beta-lactam antibiotics by cefoxitinAntimicrobial Agents and Chemotherapy, 1982
- Minimal nephrotoxicity with cephalosporin-aminoglycoside combinations in patients with neoplastic diseaseAntimicrobial Agents and Chemotherapy, 1982
- Infectious complications in the child with cancer. III. PreventionThe Journal of Pediatrics, 1981
- Infectious complications in the child with cancer. II. Management of specific infectious organismsThe Journal of Pediatrics, 1981
- In vitro and in vivo antibacterial effects of combinations of beta-lactam antibioticsAntimicrobial Agents and Chemotherapy, 1981
- Infectious complications in the child with cancer. I. Pathophysiology of the compromised host and the initial evaluation and management of the febrile cancer patientThe Journal of Pediatrics, 1981
- Three Antibiotic Regimens in the Treatment of Infection in Febrile Granulocytopenic Patients with CancerThe Journal of Infectious Diseases, 1978